LDS/Medical Tests/Wolf-Hirschhorn Syndrome, 4p16.3 Deletion

Wolf-Hirschhorn Syndrome, 4p16.3 Deletion

The Wolf-Hirschhorn syndrome (WHS) is an inherited group of anomalies defined by growth deficiency, developmental disability and characteristic facial features (microcephaly, high forehead, prominent glabella, hypertelorism, high-arched eyebrows, protruding eyes, epicanthal folds, short philtrum, distinct mouth with downturned corners, and micrognathia). It is caused by a partial deletion at 4p16.3 which contains the Wolf-Hirschhorn Syndrome Critical Region 1 (WHSCR1) and Wolf-Hirschhorn Syndrome Critical Region 2 (WHSCR2) genes. Patients with WHS may also have congenital heart disease (atrial septal defect, ventricular septal defect and/or pulmonary stenosis) Pitt-Rogers-Danks syndrome (PRDS), is a very rare disorder with deletions involving the same chromosome region. Features of PRDS include short stature and low weight of prenatal onset, moderate to severe mental retardation, seizures, and typical facial changes including microcephaly, telecanthus, upward or downward slanting palpebral fissures, prominent eyes, ocular abnormalities, hypoplastic maxilla, short philtrum, and large mouth.

Conventional G-banded cytogenetic investigations reveal a deletion in the distal part of one chromosome 4 affecting band 4p16.3 in almost 50% to 60% of WHS patients. Fluorescence In-Situ Hybridization (FISH) utilizing a WHSCR probe offers a substantially higher detection rate than traditional karyotyping and will detect the majority of patients. The preferred diagnostic test is chromosomal microarray, which detects almost all WHSCR deletions and determines the magnitude of the deletion.

  • Diagnosis and management of Wolf-Hirschhorn Syndrome
  • Diagnosis and management of Pitt-Rogers-Danks syndrome
  • Screening of neonates and family members with a history of WHS and PRDS
  • For the differential diagnosis of WHS from other syndromes that pose similar clinical presentations, such as Seckel syndrome, Charge Syndrome, Smith-Lemli-Optiz syndrome
The absence of the 4p16.3 band confirms the deletion of chromosome 4p16.3 consistent with Wolf-Hirschhorn syndrome.

Negative (No deletions involving chromosome 4p16.3 were detected)

Fluorescent In-Situ Hybridization (FISH), Comparative genomic hybridization.

Whole blood collected in sodium heparin (green top tube), amniotic fluid, miscarriage products, chorionic villi, Formalin-fixed paraffin-embedded tissue.

Stability

  • Room: 24 hours
  • Refrigerated: 72 hours
  • Frozen: unstable
PCR, Whole genome sequencing, Chromosomal microarray.
3-5 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login